Ozempic and similar products cut opioid and alcohol abuse by up to half, according to research that adds to evidence of the hugely popular blockbuster drugs’ broad potential beyond tackling obesity and diabetes.
An analysis of more than 500,000 people with a history of opioid-use disorder showed that more than 8,000 participants who were separately prescribed so-called GLP-1 drugs, such as Ozempic, had a 40 per cent lower rate of opioid overdose than those who did not.
In the more than 5,000 participants suffering from alcohol abuse and using a GLP-1 drug, there was a 50 per cent lower rate of intoxication than for those without a prescription.
您已閱讀16%（652字），剩余84%（3391字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。